These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22041855)

  • 1. Eligibility, compliance and persistence of sequential therapy with aromatase inhibitors following 2-3 years of tamoxifen in endocrine adjuvant breast cancer therapy.
    Kilic N; Myrick ME; Schmid SM; Gueth U
    Oncology; 2011; 81(3-4):151-7. PubMed ID: 22041855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eligibility, compliance and persistence of extended adjuvant endocrine therapy for breast cancer.
    Myrick ME; Schmid SM; Kilic N; Güth U
    Acta Oncol; 2012 Feb; 51(2):247-53. PubMed ID: 21985132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.
    Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
    J Clin Oncol; 2005 Aug; 23(22):5178-87. PubMed ID: 15998905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
    Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
    Cancer; 2006 Jun; 106(12):2576-82. PubMed ID: 16703595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine therapy for early breast cancer.
    Hussain SA; Williams S; Stevens A; Rea DW
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):877-88. PubMed ID: 15485321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work?
    Güth U; Myrick ME; Schötzau A; Kilic N; Schmid SM
    Breast Cancer Res Treat; 2011 Oct; 129(3):799-807. PubMed ID: 21750963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance and persistence of endocrine adjuvant breast cancer therapy.
    Güth U; Myrick ME; Kilic N; Eppenberger-Castori S; Schmid SM
    Breast Cancer Res Treat; 2012 Jan; 131(2):491-9. PubMed ID: 21976056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards optimal endocrine therapy for hormone-sensitive breast cancer: initial versus sequential adjuvant aromatase inhibition.
    Spicer J; Ellis P
    Cancer Lett; 2007 Apr; 248(2):165-74. PubMed ID: 16919870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant aromatase inhibitor therapy in patients with stage I breast cancer at a regional oncology center in Israel: implementation of a 'switching' policy in postmenopausal patients after initial tamoxifen.
    Geffen DB; Tokar M; Abu-Ghanem S; Braunstein R; Koretz M; Amir N; Delgado B; Sion-Vardi N; Ariad S; Lazarev I
    Oncology; 2013; 85(3):145-52. PubMed ID: 23988814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer.
    Buzdar A; Chlebowski R; Cuzick J; Duffy S; Forbes J; Jonat W; Ravdin P
    Curr Med Res Opin; 2006 Aug; 22(8):1575-85. PubMed ID: 16870082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy.
    Hadji P
    Crit Rev Oncol Hematol; 2010 Feb; 73(2):156-66. PubMed ID: 19299162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current adjuvant endocrine treatment of breast cancer].
    Dedes KJ; Gabriel N; Fink D
    Gynakol Geburtshilfliche Rundsch; 2008; 48(3):130-7. PubMed ID: 18566529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of adjuvant endocrine therapy of breast cancer: how much is enough?
    Ward JH
    Curr Opin Obstet Gynecol; 2010 Feb; 22(1):51-5. PubMed ID: 19952743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
    Carpenter R
    Eur J Surg Oncol; 2008 Jul; 34(7):746-55. PubMed ID: 18296017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors.
    Singh Ranger G
    J Clin Pharm Ther; 2005 Aug; 30(4):313-7. PubMed ID: 15985044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer.
    van de Velde CJ; Verma S; van Nes JG; Masterman C; Pritchard KI
    Cancer Treat Rev; 2010 Feb; 36(1):54-62. PubMed ID: 19944537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis.
    van Herk-Sukel MP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Coebergh JW; Herings RM
    Breast Cancer Res Treat; 2010 Aug; 122(3):843-51. PubMed ID: 20058066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High non-compliance in the use of letrozole after 2.5 years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial.
    Fontein DB; Nortier JW; Liefers GJ; Putter H; Meershoek-Klein Kranenbarg E; van den Bosch J; Maartense E; Rutgers EJ; van de Velde CJ
    Eur J Surg Oncol; 2012 Feb; 38(2):110-7. PubMed ID: 22172646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women.
    Mouridsen HT; Robert NJ
    Eur J Cancer; 2005 Aug; 41(12):1678-89. PubMed ID: 16098456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis.
    Hadji P; Ziller V; Kyvernitakis J; Bauer M; Haas G; Schmidt N; Kostev K
    Breast Cancer Res Treat; 2013 Feb; 138(1):185-91. PubMed ID: 23334803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.